Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Understand which fund covers more stocks between Total Market and Sp 500 Retirement and how this impacts diversification and potential returns.
28,617 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
XRP has cooled off near $1.50 after a sharp drop. Before you buy the dip, learn what drives XRP's price, how Ripple's...
When online gaming collides with real-world crime, the financial fallout hits households hard. Learn practical steps ...
As AI workloads expand, data center power stocks are seeing a fresh wave of orders and upgraded guidance. This report...
Capital moves matter. Capricorn Investment Group reduced its Navitas Semiconductor stake by about 1.19 million shares...
DexCom and Insulet sit at the heart of diabetes technology. This in-depth look examines growth drivers, financials, a...
Mega rounds in drones and AI-driven drug discovery signal big shifts in tech investing. This piece explains the perso...
Markets toppled and surged in swings as investors assessed a policy path that some say appears improvised. Analysts w...
The latest data show the average american savings rate falling to 2.6% in April, a sign of rising household stress. A...
NVIDIA revealed a $500 million strategic deal with CORNING to bolster optical connectivity for AI data centers, spark...
ProShares Ultra Silver aimed to double silver's move, but daily resets and volatility trimmed returns, reshaping expe...
U.S. labor data at month-end point to a cooling but stable job market, with initial claims around the low 200,000s an...